Leap Therapeutics Statistics

Total Valuation

LPTX has a market cap or net worth of $140.43 million. The enterprise value is $62.43 million.

Market Cap	140.43M
Enterprise Value	62.43M

Important Dates

The next estimated earnings date is Friday, November 15, 2024, before market open.

Earnings Date	Nov 15, 2024
Ex-Dividend Date	n/a

Share Statistics

LPTX has 38.26 million shares outstanding. The number of shares has increased by 142.56% in one year.

Shares Outstanding	38.26M
Shares Change (YoY)	+142.56%
Shares Change (QoQ)	+44.82%
Owned by Insiders (%)	0.25%
Owned by Institutions (%)	26.01%
Float	26.09M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.13
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.10, with a Debt / Equity ratio of 0.01.

Current Ratio	5.10
Quick Ratio	5.08
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -80.54% and return on invested capital (ROIC) is -53.63%.

Return on Equity (ROE)	-80.54%
Return on Assets (ROA)	-45.62%
Return on Capital (ROIC)	-53.63%
Revenue Per Employee	n/a
Profits Per Employee	-$1.12M
Employee Count	54
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +102.76% in the last 52 weeks. The beta is 0.22, so LPTX's price volatility has been lower than the market average.

Beta (5Y)	0.22
52-Week Price Change	+102.76%
50-Day Moving Average	2.87
200-Day Moving Average	2.65
Relative Strength Index (RSI)	60.20
Average Volume (20 Days)	449,743

Short Selling Information

The latest short interest is 723,536, so 1.89% of the outstanding shares have been sold short.

Short Interest	723,536
Short Previous Month	899,103
Short % of Shares Out	1.89%
Short % of Float	2.77%
Short Ratio (days to cover)	4.96

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-64.70M
Pretax Income	-53.37M
Net Income	-60.34M
EBITDA	-64.69M
EBIT	-64.70M
Earnings Per Share (EPS)	-$1.98

Full Income Statement

Balance Sheet

The company has $78.48 million in cash and $482,000 in debt, giving a net cash position of $78.00 million or $2.04 per share.

Cash & Cash Equivalents	78.48M
Total Debt	482,000
Net Cash	78.00M
Net Cash Per Share	$2.04
Equity (Book Value)	65.79M
Book Value Per Share	1.72
Working Capital	63.99M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-50.06M
Capital Expenditures	n/a
Free Cash Flow	-50.06M
FCF Per Share	-$1.31

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LPTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-142.56%
Shareholder Yield	-142.56%
Earnings Yield	-42.97%
FCF Yield	-35.64%

Analyst Forecast

The average price target for LPTX is $10.40, which is 183.38% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.40
Price Target Difference	183.38%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-24.20%

Stock Forecasts

Stock Splits

The last stock split was on June 21, 2023. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Jun 21, 2023
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1